Therefore, we examined the expression of the PRMT enzymes across hematological malignancies, particularly leukemias, and focused on the role of PRMT7 in T-ALL pathogenesis and prognosis. This evidence concerns the gene PRMT7 and acute lymphoblastic leukemia.